17/05/2023 Commercialisation boost for the Institute’s fundamental research research |commercialisation |innovation |impact |funding |immunology |liston |flow cytometry |babraham research campus
20/10/2022 Institute spin-out, Enhanc3D Genomics, raises £10 million in Series A financing gene expression |3d genome |spin out |commercialisation |schoenfelder
26/05/2022 Institute spin-out, ENHANC3D GENOMICS goes from strength to strength gene expression |3d genome |spin out |commercialisation |schoenfelder
25/11/2021 Dr Jon Houseley appointed Head of Knowledge Exchange and Commercialisation knowledge exchange |houseley |commercialisation |institute
22/06/2020 Institute spin-out joins Start Codon’s business acceleration programme commercialisation |institute |3d genome |disease |spin out |dna |genome organisation |enhancers |schoenfelder
09/11/2018 Institute spin-out announces early exclusive licence of oncology-targeted Humabody® antibodies |babraham research campus |cancer |commercialisation |immunology |impact |spin out
26/10/2016 Insights to real-life research commercialisation |epigenetics |facilities |knowledge exchange |lymphocyte signalling |nuclear dynamics |science |signalling |stem insight |teachers
10/10/2016 Babraham Institute spin-out Crescendo Biologics enters deal worth up to $790m babraham research campus |commercialisation |immunology |industry
19/02/2016 Babraham Institute Shortlisted for ‘Excellence with Impact’ Competition commercialisation |impact |knowledge exchange |public engagement
10/06/2015 Boost to Babraham Institute’s knowledge exchange and commercialisation commercialisation |funding |knowledge exchange
25/04/2014 £6M to help early bioscience companies flourish commercialisation |knowledge exchange |press release
28/03/2014 Babraham Institute spin-out Crescendo Biologics Wins Cambridge Business Innovation Award commercialisation |knowledge exchange
11/03/2014 Ministers visit the Babraham Research Campus commercialisation |knowledge exchange |press release
17/12/2013 Babraham spin-out Crescendo Biologics Raises £17.5M in Series A Financing commercialisation |knowledge exchange
09/07/2013 Babraham scientists establish cancer-focussed Knowledge Exchange collaboration with AstraZeneca commercialisation |knowledge exchange
20/05/2013 The Babraham Institute announces the formation of Babraham Commercialisation Services Ltd commercialisation |knowledge exchange
24/05/2012 Minister opens new facilities to boost bioscience business at Babraham commercialisation |knowledge exchange
11/01/2012 Babraham joins forces with The University of Cambridge's ideaSpace to accelerate enterprise commercialisation
18/08/2011 Babraham epigenetics research paves the way for a better understanding of unexplained infertility commercialisation |knowledge exchange
28/03/2011 Babraham researchers discover how tumour cells acquire resistance to new emerging drugs commercialisation |knowledge exchange
24/03/2011 Babraham Research Campus receives £44M boost for bioscience innovation commercialisation |knowledge exchange